Vision and Mission

A government partner in improving healthcare systems.

Read More

Commitment

Commitment to ethics and compliance.

Read More

IPMG Role

Constructive dialogue with government and stakeholders.

Read More

Parturient ad enim lobortis aptent suscipit penatibus placerat finibus rutrum libero congue nisl proin arcu tincidunt iaculis sagittis vestibulum molestie curae nisi consectetur est praesent purus

Read More

Parturient ad enim lobortis aptent suscipit penatibus placerat finibus rutrum libero congue nisl proin arcu tincidunt iaculis sagittis vestibulum molestie curae nisi consectetur est praesent purus

Read More

Suscipit dis iaculis est curabitur ac hendrerit cras ut sociosqu fermentum eros bibendum odio nulla nullam nunc lectus feugiat tempus posuere volutpat pharetra proin consectetuer sit

Read More

Lacus arcu magna potenti molestie augue ac feugiat cras aliquam primis tristique maecenas cubilia curae tortor volutpat parturient felis porttitor blandit sollicitudin ante libero at malesuada

Read More

Industry News

Image

PMG Stakeholder's Forum 2024 National Strategy for Innovative Medicines and Vaccines

Today, at the IPMG Stakeholders’ Forum, we proudly launched the IPMG Manifesto—a strategic roadmap to transform access to medical innovation in Indonesia.

Image

IPMG and JPMA Meeting with Badan POM

Recently, IPMG joined a meeting between the Head of BADAN PENGAWAS OBAT DAN MAKANAN, Prof. dr.Taruna Ikrar, M.Biomed., Ph.D and Japan Pharmaceutical Manufacturers Association (JPMA), where we witnessed his passion and determination to elevate Badan POM to WHO Listed Authority (WLA) status. This ambitious vision has been a consistent focus for Prof. Ikrar, who reiterated his commitment during the meeting and warmly invited JPMA to share ideas or initiatives to support BPOM in achieving this goal within the next year.

Image

Bayer | Consumer Health Launches Indonesia's Largest Rooftop Solar Power System in Multinational Pharma Industry

Congratulations Bayer Indonesia, one of IPMG member companies, to have reinforced its commitment to Indonesia's climate goals by inaugurating the country's largest rooftop solar power system in the multinational pharmaceutical sector at its Cimanggis plant, Depok, West Java. Utilizing 3,770 photovoltaic modules, this solar power installation generates 2,054 kWp, will eliminate carbon emissions by 2,073 metric tons annually, equivalent to planting 95,000 trees or removing 450 cars from the road.

Image

Challenges in the Pharmaceutical Business

The pharmaceutical industry, particularly in Indonesia, faces several challenges. The first is that 95% of raw materials for medicines are still imported, placing a financial burden on producers—exacerbated by fluctuations in the Rupiah's exchange rate against foreign currencies.

Press Release

Image

IPMG Champions Manifesto to Drive the Formulation of a National Integrated Strategy to Accelerate Access to Innovative Medicines and Vaccines

Jakarta, 12 Desember 2024 – International Pharmaceutical Manufacturers Group (IPMG), yang mewakili perusahaan riset biofarmasi global terkemuka di Indonesia, hari ini mengadakan Forum Diskusi Pemangku Kepentingan untuk pertama kalinya

Image

IPMG Promotes Synergy to Accelerate Access to Innovative Medicines for Indonesia's Economic Growth

Jakarta, 13 November 2024 – The International Pharmaceutical Manufacturers Group (IPMG), an association representing leading research-based multinational biopharmaceutical companies operating in Indonesia, today issued a call to action to develop a national strategy that can strengthen Indonesia's health system and drive economic growth through expanded access to innovative medicines

Image

Dr. Ait-Allah Mejri to Step Down as IPMG Chair in March 2025; Evie Yulin Named Successor

Jakarta, — The International Pharmaceutical Manufacturers Group (IPMG), representing over 27 leading research-based pharmaceutical companies committed to advancing healthcare in Indonesia

Our Member

  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients